LT3268480T - Priemonės ir būdai, skirti panaudoti ląstelių dalijimosi lokusus ląstelių proliferacijos kontroliavimui - Google Patents

Priemonės ir būdai, skirti panaudoti ląstelių dalijimosi lokusus ląstelių proliferacijos kontroliavimui

Info

Publication number
LT3268480T
LT3268480T LTEP16760977.5T LT16760977T LT3268480T LT 3268480 T LT3268480 T LT 3268480T LT 16760977 T LT16760977 T LT 16760977T LT 3268480 T LT3268480 T LT 3268480T
Authority
LT
Lithuania
Prior art keywords
tools
cells
methods
cell division
control proliferation
Prior art date
Application number
LTEP16760977.5T
Other languages
English (en)
Inventor
Andras Nagy
Claudio MONETTI
Qin LIANG
Original Assignee
Sinai Health System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sinai Health System filed Critical Sinai Health System
Publication of LT3268480T publication Critical patent/LT3268480T/lt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/65—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression using markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Reproductive Health (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
LTEP16760977.5T 2015-03-09 2016-03-09 Priemonės ir būdai, skirti panaudoti ląstelių dalijimosi lokusus ląstelių proliferacijos kontroliavimui LT3268480T (lt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562130258P 2015-03-09 2015-03-09
US201562130270P 2015-03-09 2015-03-09
PCT/CA2016/050256 WO2016141480A1 (en) 2015-03-09 2016-03-09 Tools and methods for using cell division loci to control proliferation of cells

Publications (1)

Publication Number Publication Date
LT3268480T true LT3268480T (lt) 2021-07-26

Family

ID=56879714

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP16760977.5T LT3268480T (lt) 2015-03-09 2016-03-09 Priemonės ir būdai, skirti panaudoti ląstelių dalijimosi lokusus ląstelių proliferacijos kontroliavimui

Country Status (12)

Country Link
US (2) US20180044686A1 (lt)
EP (2) EP3268480B1 (lt)
JP (3) JP6938380B2 (lt)
KR (2) KR20240013291A (lt)
CN (2) CN115323000A (lt)
AU (1) AU2016228914B2 (lt)
CA (1) CA2978633A1 (lt)
DK (1) DK3268480T3 (lt)
HU (1) HUE055500T2 (lt)
IL (1) IL254385B (lt)
LT (1) LT3268480T (lt)
WO (1) WO2016141480A1 (lt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7099967B2 (ja) * 2016-07-01 2022-07-12 リサーチ ディベロップメント ファウンデーション 幹細胞由来移植片からの増殖性細胞の排除
GB2588249B (en) * 2017-06-12 2023-01-04 Sinai Health Sys Allograft tolerance without the need for systemic immune suppression
CN108048405A (zh) * 2018-01-15 2018-05-18 上海市东方医院 稳定表达人内源性INav的细胞模型及其制备方法和用途
WO2020118447A1 (en) * 2018-12-13 2020-06-18 Sinai Health System Immunomodulatory cells and uses thereof
EP3942298A4 (en) * 2019-03-21 2022-12-21 The UAB Research Foundation METHOD OF INCREASING CELLULAR SENSITIVITY TO COMPLEMENT-MEDIATED LYSIS
CN112921052B (zh) * 2019-12-06 2023-07-21 中国科学院分子细胞科学卓越创新中心 体内细胞增殖标记与示踪系统及其应用
US11661459B2 (en) 2020-12-03 2023-05-30 Century Therapeutics, Inc. Artificial cell death polypeptide for chimeric antigen receptor and uses thereof
TW202241935A (zh) 2020-12-18 2022-11-01 美商世紀治療股份有限公司 具有可調適受體專一性之嵌合抗原受體系統

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9703633D0 (en) * 1997-02-21 1997-04-09 Imp Cancer Res Tech Cancer therapy
AU2005244988C1 (en) * 2004-05-21 2012-06-28 President And Fellows Of Harvard College Synthesis of tetracyclines and analogues thereof
CA2725953A1 (en) * 2007-05-29 2008-12-11 Christopher B. Reid Methods for production and uses of multipotent cell populations, pluripotent cell populations, neuronal cell populations, and muscle cell populations
EP2300023A2 (en) * 2008-05-16 2011-03-30 Genelux Corporation Microorganisms for preventing and treating neoplasms accompanying cellular therapy
CA2760687A1 (en) * 2009-05-01 2010-11-04 Ophthotech Corporation Methods for treating or preventing ophthalmological diseases
US20120171213A1 (en) * 2009-09-10 2012-07-05 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Method of treating tumors

Also Published As

Publication number Publication date
JP2023103412A (ja) 2023-07-26
EP3268480A4 (en) 2018-07-04
JP2018507701A (ja) 2018-03-22
CN107849583A (zh) 2018-03-27
JP7284213B2 (ja) 2023-05-30
CN115323000A (zh) 2022-11-11
KR20240013291A (ko) 2024-01-30
EP3268480A1 (en) 2018-01-17
IL254385B (en) 2021-04-29
EP3268480B1 (en) 2021-05-19
US20180044686A1 (en) 2018-02-15
KR102628872B1 (ko) 2024-01-26
IL254385A0 (en) 2017-11-30
JP2021166529A (ja) 2021-10-21
CA2978633A1 (en) 2016-09-15
US20220325289A1 (en) 2022-10-13
CN107849583B (zh) 2022-01-14
JP6938380B2 (ja) 2021-09-22
KR20170136528A (ko) 2017-12-11
EP3929298A1 (en) 2021-12-29
AU2016228914A1 (en) 2017-09-21
DK3268480T3 (da) 2021-07-26
WO2016141480A1 (en) 2016-09-15
AU2016228914B2 (en) 2022-04-21
HUE055500T2 (hu) 2021-11-29

Similar Documents

Publication Publication Date Title
IL292504B1 (en) Methods of preparing t cells for t cell therapy
HK1258739A1 (zh) 多能細胞的基因組工程改造
HK1255161A1 (zh) 用於過繼性細胞治療的工程細胞
IL254385B (en) Devices and methods for using a cell division site to control cell division
HK1245829A1 (zh) 受控消除治療性細胞的方法
HK1244826A1 (zh) 用於過繼細胞治療的方法和組合物
IL250072A0 (en) Transgenic cells for stress cell therapy
EP3370743A4 (en) METHODS OF PREPARING LYMPHOCYTES FOR ADOPTIVE TRANSFER THERAPY OF T-CELLS
SG11201703493SA (en) Cell culture insert
HK1247104A1 (zh) 使用luterion抑制癌細胞中端粒酶的方法
HK1250931A1 (zh) 誘導有絲分裂期後細胞的細胞分裂的方法
RS63284B1 (sr) Ćelijska kultura
GB201608060D0 (en) Method of culturing T cells
SG11201706604PA (en) Method for evaluating ability of cells to grow into sheet
IL274746A (en) A method for cell culture
IL247890A0 (en) Methods related to stem cells
GB201504291D0 (en) PV cells
SG11201609269TA (en) Method of culturing cells
GB201511482D0 (en) Culture of RPE cells
AU2015900777A0 (en) Cell culture method
AU2015900752A0 (en) Cell culture method
AU2014902203A0 (en) Method of producing cells for adoptive cell transfer